Adeno-associated virus integration: virus versus vector

Gene Therapy
R H Smith

Abstract

Although a large percentage of the world population is seropositive for exposure to various strains of adeno-associated virus (AAV), a human parvovirus, AAV has never been identified as an etiologic agent of human disease. Most likely contributing to the pronounced lack of pathogenicity is the fact that AAV is a naturally defective virus that requires a helper virus for productive replication of its genome. Another unusual aspect of wild-type AAV biology is the ability of the virus to establish latent infection by preferential integration of its genome into a specific locus of human chromosome 19. Site-specific integration was a major impetus for the development of recombinant AAV vectors, which typically lack all AAV coding sequences. It was soon realized, however, that expression of at least one species of the virally encoded initiator proteins, Rep78 or Rep68, is necessary for targeted integration of AAV-derived DNA constructs to occur. This article will present a chronological outline of studies characterizing site-specific integration of wild-type AAV sequences and the quasi-random target site selection observed with recombinant AAV vectors.

References

Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R M KotinK I Berns
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·C GiraudK I Berns
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·M D WeitzmanR A Owens
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·R M LindenK I Berns
Mar 1, 1997·Nature Medicine·K J FisherJ M Wilson
May 20, 1998·Nature Genetics·C H MiaoM A Kay
Jun 5, 2003·Nature Genetics·Hiroyuki NakaiMark A Kay
Aug 13, 1965·Science·R W ATCHISONW M HAMMON
Aug 17, 2005·Journal of Virology·Daniel G MillerDavid W Russell
Nov 14, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria L CortésXandra O Breakefield

❮ Previous
Next ❯

Citations

Dec 23, 2008·Eye·K A WilliamsD J Coster
Mar 6, 2009·Gene Therapy·A S Beutler, M Reinhardt
Jun 24, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Albert GrinshpunEithan Galun
May 14, 2011·Tissue Engineering. Part C, Methods·Michelle LockeP Rod Dunbar
Aug 5, 2009·Nucleic Acids Research·Gijsbert P van NieropManuel A F V Gonçalves
Nov 10, 2011·Viruses·Masayuki Horie, Keizo Tomonaga
Jan 13, 2015·Molecular Therapy. Methods & Clinical Development·Andrea Lh ArnettJeffrey S Chamberlain
Aug 10, 2010·Annual Review of Microbiology·Matthew D WeitzmanMira S Chaurushiya
Apr 21, 2011·Expert Opinion on Biological Therapy·Janice Y Chou, Brian C Mansfield
Dec 23, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jaichandran SivalingamOi Lian Kon
Oct 17, 2012·Biotechnology Advances·Shuohao Huang, Masamichi Kamihira
Apr 21, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mauro Giacca, Serena Zacchigna
Dec 6, 2011·Biochemical and Biophysical Research Communications·Shuohao HuangMasamichi Kamihira
Oct 15, 2009·International Journal of Pharmaceutics·Johannes GeigerCarsten Rudolph
Nov 12, 2009·Pharmacology & Therapeutics·James L Kreindler
Aug 25, 2009·Journal of Neuroscience Methods·Alessandro PapaleRiccardo Brambilla
Jul 27, 2010·Journal of Cellular Physiology·Henrik Landgren, Maurice A Curtis
Feb 14, 2015·Annals of the New York Academy of Sciences·Mart Krupovic, Patrick Forterre
Aug 25, 2015·Nature Genetics·Jean-Charles NaultJessica Zucman-Rossi
Dec 16, 2010·Human Vaccines·Mark C JohnsonRoland Tisch
Jan 19, 2015·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Francesco Saverio Tedesco
Jan 23, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Javier Torres-TorronterasRamon Martí
Oct 19, 2016·Journal of Hepatology·Kornelius SchulzeAugusto Villanueva
Nov 30, 2016·Human Gene Therapy·Lisa M KattenhornSamuel C Wadsworth
Oct 5, 2012·Acta Biochimica Et Biophysica Sinica·Qiantong XiangDepei Liu
Sep 25, 2017·Biotechnology and Bioengineering·David Sharon, Amine Kamen
Jan 10, 2018·Frontiers in Neuroscience·Jean DelbekeDimiter Prodanov
Dec 19, 2017·Frontiers in Microbiology·Paweł WawrzyniakDariusz Bartosik
Aug 2, 2018·Human Gene Therapy Methods·Lucie Chansel-DebordeauxBenjamin Dehay
Feb 23, 2009·Advanced Materials·David N NguyenDaniel G Anderson
Jan 13, 2016·World Journal of Gastroenterology : WJG·Yi-Gang WangYan-Fang Sun
Dec 6, 2018·Nature Reviews. Rheumatology·Magali Cucchiarini, Henning Madry
Sep 10, 2020·Frontiers in Molecular Neuroscience·Joseph Edward RittinerBoris Kantor
May 5, 2020·Frontiers in Immunology·Giuseppe RonzittiFederico Mingozzi
Dec 31, 2019·Journal of Hematology & Oncology·Lauren C FleischerSunil S Raikar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
R M LindenKenneth I Berns
European Journal of Biochemistry
K Van CraenenbroeckG Haegeman
© 2022 Meta ULC. All rights reserved